Sleep Solutions
HCID Member | Medical Devices & Tech  Advamed Member
801 Cromwell Park Drive, Suite 108
Glen Burnie, Maryland 21061 USA
phone: 877-753-3775
fax:
Symbol Private
Exchange Private
Founded 1992
Employees 14
www.sleepsolutions.com
Research Sector Medical Devices & Tech
Summary Description
Diagnostic Service Provider of Home Testing and Evaluation of Sleep-Disordered Breathing
Management
Michael J. Thomas, President and CEO; Gary Corbett, CIO and VP Operations; Jan Barker, Chairman of the Board
Keywords
Sleep-disordered breathing, NovaSom, Home-diagnostic system, MediTrack System, Digital-signal processing technology

Comment | Printable Version | Dec. 31, 2008
If you work for Sleep Solutions and want to update this profile, click here

Description
Sleep Solutions, Inc. (SSI) is a private diagnostic service provider of home testing and evaluation of sleep-disordered breathing conditions, including obstructive sleep apnea (OSA).
Products / Services
NovaSom QSG enables patients to undergo testing for OSA in the comfort and convenience of their homes, while offering physicians an expeditious, cost-effective and accurate alternative to in-laboratory sleep studies. Sleep Solutions' MediTrack System provides secure, patient-reported health information and outcomes tracking services to aid therapeutic decisions and disease state management. SSI's at-home pulse oximetry service facilitates the required testing of Medicare patients receiving oxygen at home; it delivers simple and clinically-accurate overnight pulse oximetry devices to patients' homes and instructs them on how to operate the devices. The devices are then returned to SSI's Medicare-approved Independent Diagnostic Testing Facility (IDTF).
Technology / Differentiation
To date, NovaSom QSG is the only physician prescribed device cleared by the FDA that is specifically designed for unattended and unassisted use in the patient's home and clinically proven to be equivalent to in-laboratory polysomnography (PSG), the current standard in OSA diagnosis. The device consists of a patient module worn on the wrist, a bedside unit, an airflow sensor worn on the face, an effort sensor worn around the chest and a finger sensor. NovaSom QSG utilizes patented audio digital-signal processing (DSP) technology to sense, analyze, and process the patient's respiratory sounds and to convert these sounds to airflow volume. The back end of this process is Sleep Solutions Study Viewer, an electronic analysis system utilizing proprietary algorithms for automated scoring and generation of concise yet conclusive diagnostic reports. The NovaSom QSG service is enhanced by the company's proprietary MediTrack System, a comprehensive healthcare management system for the direct-to-patient delivery of testing services and medical products.
Market / Customers
OSA is a serious and potentially life-threatening sleep disorder affecting as many as 18 million Americans; as many as 85% of individuals with sleep apnea are currently undiagnosed. The OSA diagnostic testing market is projected to exceed $3 billion by the end of 2008 and is expected to grow at an annual rate of 20-30% until 2013.
Competitors / Substitutes / Alternatives
The standard method for diagnosing OSA requires placing the patient in a sleep laboratory overnight and performing polysomnography (PSG). This process is expensive, ranging from $1,000 to over $2,500 per night. The estimated 2,200 sleep laboratories in the U.S. can only accommodate a fraction of the patients that require diagnosis. Patients often resist submitting to this uncomfortable and expensive procedure.
Status
Sleep Solutions announced that it had secured $20.5 million in additional venture funding from the TPG Biotechnology II fund in May 2008. NovaSom QSG is currently available with a prescription and is fully reimbursable by most U.S. health insurance firms.


2009-01-06-3641